Company / Share Buybacks
Amphstar Pharmaceuticals, Inc. Share Buybacks History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
$75.6M
FY2025
5-year range
$28.9M / $85.5M
FY2021-FY2025
Trend
-11.6%
vs FY2024
Sector context
#23 of 48
Health Care
What the data says
At $76M, Amphstar Pharmaceuticals, Inc.'s share buybacks ranks #23 of 48 in the Health Care sector. Share Buybacks has fluctuated over the past 10 years, ranging from $10M in FY2016 to $85M in FY2024.
Based on SEC 10-K filings.
$76M in FY2025 with a 5-year CAGR of +25.3%.
Improved from $58M to $76M over the past 2 years.
Health Care sector context is included.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- +23.7%
- 5-Year CAGR
- +25.3%
- 10-Year CAGR
- -
Sector benchmark
#23 of 48 in Health CareTop 48% of 48This company $75.6M Sector average $611.9M
▼
-87.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +25.3%, indicating consistent growth.
- In FY2025, share buybacks decreased 11.6% year-over-year.
- Ranks #23 out of 48 companies in the Health Care sector.
- Peak share buybacks was recorded in FY2024.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $75.6M | -11.6% |
| FY2024 | $85.5M | +47.0% |
| FY2023 | $58.1M | +45.7% |
| FY2022 | $39.9M | +38.2% |
| FY2021 | $28.9M | +18.2% |
| FY2020 | $24.4M | +9.6% |
| FY2019 | $22.3M | -11.0% |
| FY2018 | $25.0M | -18.5% |
| FY2017 | $30.7M | +210.3% |
| FY2016 | $9.9M | +0.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026